Amgen has firmed up its lead in the race to bring the first CGRP inhibitor to market for migraine after
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
After Danish and Swedish, Solidsoft Reply, the Reply group company specialising in enterprise strength solutions on the Microsoft Azure cloud
This year’s Med-Tech Innovation Expo will see 3D printing and additive manufacturing group Stratasys demonstrate how its advanced 3D printing
Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology,
Pharmaceutical wholesaler United Drug has announced a €40 million investment in technology and innovation at its headquarters at Citywest in
Inoviem Scientific, a contract research biotech (CRB), has secured funding of €750k from existing financial partners to support the company’s
Smart bandages that can detect how a wound is healing and send messages back doctors could be trialled within the
On April 18, 2017 Fujifilm announced the completion of a $93-million cGMP production facility in Texas. The facility expansion is
The first patient has been recruited in an exploratory Phase Ib clinical trial of Targovax’s second product from its RAS-peptide
This year’s Medtec Europe showed a record attendance with a 7% increase in overall visits. The event attracted 6,816 attendees
Irish medtech firm Diaceutics is set to add 30 jobs to its workforce in the coming year, as the company
Targovax has recruited its first patient in a Phase Ib trial for its new cancer vaccine TG02 targeting mutations of
Allergan, a global biopharmaceutical company, announced that it has entered into a clinical trial agreement with Novartis to conduct a Phase
With Brexit centre stage, there is a temptation for all attention in Ireland to focus on two topics: how much
The medtech sector has welcomed the vote from the European Parliament to endorse new regulations on in vitro diagnostic medical
A new government report shows that digital health companies in the UK generated a turnover of over £1 billion in
Flare-ups in chronic obstructive pulmonary disease, the UK’s fourth leading cause of death, can be reduced by 20% by a
Two startups in the fields of synthetic biology, Biosyntia and FGen, have struck a partnership to identify promising microbial strains.
Contrary to some political claims, the U.S. Food and Drug Administration approved more drugs, and two to three months faster on average, than